Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: A systematic review

AIDS

Volumn 26, Issue SUPPL.2, 2012, Pages

  Mayston, Rosie ^a   Kinyanda, Eugene ^b,c   Chishinga, Nathaniel ^d,e   Prince, Martin ^a   Patel, Vikram ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c Senior EDCTP Fellowship   (South Africa)

^d Anatomy Department   (Zambia)

^e Department of Clinical Research ^*  (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL CONSUMPTION; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; COGNITIVE DEFECT; COGNITIVE THERAPY; CORRELATION ANALYSIS; DEPRESSION; DEVELOPING COUNTRY; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW INCOME COUNTRY; MEDICAL LITERATURE; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; MIDDLE INCOME COUNTRY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SOCIAL ASPECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ALCOHOLISM; ANTI-RETROVIRAL AGENTS; DEPRESSIVE DISORDER; HIV INFECTIONS; HUMANS; MENTAL DISORDERS; PATIENT COMPLIANCE; POVERTY; TREATMENT OUTCOME;

EID: 84872862861     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835bde0f     Document Type: Review

References (66)

1. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158:725-730. (Pubitemid 32429839)
2. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58:721-728. (Pubitemid 32717795)
3. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J, HIV Epidemiology Research Study Group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001; 285:1466-1474. (Pubitemid 32221895)
4. Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al., AdICoNA Study Group. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr 2002; 31 (Suppl 3):S123-S127; Review. (Pubitemid 35453571)
5. Collins PY, Holman AR, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS 2006; 20:1571-1582; Review. (Pubitemid 44162398)
6. Mello VA, Segurado AA, Malbergier A. Depression in women living with HIV: clinical and psychosocial correlates. Arch Womens Ment Health 2010; 13:193-199; Epub 2009 Sep 16.
7. Patel R, Kassaye S, Gore-Felton C, Wyshak G, Kadzirange G, Woelk G, Katzenstein D. Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe. AIDS Care 2009; 21:1517-1527.
8. Báez Feliciano DV, Gómez MA, Fernández-Santos DM, Quintana R, Rios-Olivares E, Hunter-Mellado RF. Profile of Puerto Rican HIV/AIDS patients with early and nonearly initiation of injection drug use. Ethn Dis 2008; 18 (2 Suppl 2):S2-99-S2-104.
9. Malta M, Bastos FI, da Silva CM, Pereira GF, Lucena FF, Fonseca MG, Strathdee SA. Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men. J Acquir Immune Defic Syndr 2009; 52:629-635.
10. Etienne M, Hossain M, Redfield R, Stafford K, Amoroso A. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries. J Int Assoc Physicians AIDS Care (Chic) 2010; 9:98-103; Epub 2010 Mar.
11. Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK. Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Trop Med Int Health 2008; 13:328-333; Epub 2008 Feb 21. (Pubitemid 351501541)
12. Jaquet A, Ekouevi DK, Bashi J, Aboubakrine M, Messou E, Maiga M, et al. Alcohol use and nonadherence to antiretroviral therapy in HIV-infected patients in West Africa. Addiction 2010; 105:1416-1421; Epub 2010 Jun 7.
13. Peltzer K, Friend-du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health 2010; 10:111.
14. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIVclinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr 2009; 52:280-289.
15. Farley J, Miller E, Zamani A, Tepper V, Morris C, Oyegunle M, et al. Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence. J Int Assoc Physicians AIDS Care (Chic) 2010; 9:218-226.
16. Beyene KA, Gedif T, Gebre-Mariam T, Engidawork E. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiol Drug Saf 2009; 18:1007-1015.
17. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIVinfected persons: a prospective study in Southwest Ethiopia. BMC Public Health 2008; 8:265.
18. Campos LN, Guimaraes MD, Remien RH. Anxiety and depression symptoms as risk factors for nonadherence to antiretroviral therapy in Brazil. AIDS Behav 2010; 14:289-299; Epub 2008 Jul 22.
19. Wang H, Zhou J, He G, Luo Y, Li X, Yang A, et al. Consistent ART adherence is associated with improved quality of Life, CD4 counts, and reduced hospital costs in central China. AIDS Res Hum Retroviruses 2009; 25:757-763.
20. Abera K, Gedif T, Engidawork E, Gebre-Mariam T. Quality of life of people living with HIV/AIDS and on highly active antiretroviral therapy in Ethiopia. Afr J AIDS Res 2010; 9:31-40.
21. Wisaksana R, Indrati AK, Fibriani A, Rogayah E, Sudjana P, Djajakusumah TS, et al. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction 2010; 105:1055-1061; Epub 2010 Mar 10.
22. Shin S, Munoz M, Espiritu B, Zeladita J, Sanchez E, Callacna M, et al. Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru. J Int Assoc Physicians AIDS Care (Chic) 2008; 7:74-81; Epub 2008 Mar 4.
23. Bhat VG, Ramburuth M, Singh M, Titi O, Antony AP, Chiya L, et al. Factors associated with poor adherence to antiretroviral therapy in patients attending a rural health centre in South Africa. Eur J Clin Microbiol Infect Dis 2010; 29:947-953; Epub 2010 May 14.
24. Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S. Psychological distress and adherence to highly active antiretroviral therapy (HAART) in Uganda: a pilot study. Afr Health Sci 2009; 9 (Suppl 1):S2-7.
25. Sharma M, Singh RR, Laishram P, Kumar B, Nanao H, Sharma C, Ahmed T. Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment. Int J Drug Policy 2007; 18:319-325; Epub 2007 Jun 21. (Pubitemid 47161057)
26. Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses 2010; 26:685-691.
27. Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, Bangsberg DR. Longitudinal antiretroviral adherence in HIVR Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 2009; 13 (Suppl 1):82-91; Epub 2009.
28. Venkatesh KK, Srikrishnan AK, Mayer KH, Kumarasamy N, Raminani S, Thamburaj E, et al. Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS 2010; 24:795-803; Epub 2010 Nov 22.
29. Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF, Fakande I. The effect of psychological distress on medication adherence in persons with HIV infection in Nigeria. Psychosomatics 2010; 51:68-73.
30. Tadios Y, Davey G. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Ethiop Med J 2006; 44:237-244.
31. Dahab M, Charalambous S, Karstaedt AS, Fielding KL, Hamilton R, La Grange L, et al. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study. BMC Public Health 2010; 10:430.
32. Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case-control study. AIDS Res Ther 2011; 8:8.
33. Marcellin F, Boyer S, Protopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S, et al., EVAL Study Group. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116). Trop Med Int Health 2008; 13:1470-1478; Epub 2008 Nov 5.
34. Martinez P, Andia I, Emenyonu N, Hahn JA, Hauff E, Pepper L, Bangsberg DR. Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest Uganda. AIDS Behav 2008; 12:605-612; Epub 2007 Oct 30. (Pubitemid 351873638)
35. Jordan MR, La H, Nguyen HD, Sheehan H, Lien TT, Duong DV, et al. Correlates of HIV-1 viral suppression in a cohort of HIVpositive drug users receiving antiretroviral therapy in Hanoi, Vietnam. Int J STD AIDS 2009; 20:418-422.
36. Olley BO, Seedat S, Stein DJ. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6- month follow-up study. J Psychosom Res 2006; 61:479-484. (Pubitemid 44441442)
37. Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care 2007; 19:626-636. (Pubitemid 46763737)
38. Bajunirwe F, Tisch DJ, King CH, Arts EJ, Debanne SM, Sethi AK. Quality of life and social support among patients receiving antiretroviral therapy in western Uganda. AIDS Care 2009; 21:271-279.
39. Wig N, Lekshmi R, Pal H, Ahuja V, Mittal CM, Agarwal SK. The impact of HIV/AIDS on the quality of life: a cross sectional study in north India. Indian J Med Sci 2006; 60:3-12. (Pubitemid 43175851)
40. Kaharuza FM, Bunnell R, Moss S, Purcell DW, Bikaako-Kajura W, Wamai N, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav 2006; 10 (4 Suppl):S105-S111.
41. Khochak HE, Noorifard M, Kashi AH, Arbabi M, Kheirandish P, Badie BM, Rasoolinejad M. Evaluation of depression in HIV/ AIDS patients refering to behavioral counselling center of Imam Khomeini Hospital. Acta Medica Iranica 2009; 47:193-196.
42. Yu XN, Lau JT, Mak WW, Cheng YM, Lv YH, Zhang JX. Risk and protective factors in association with mental health problems among people living with HIV who were former plasma/blood donors in rural China. AIDS Care 2009; 21:645-654.
43. Boivin MJ, Busman RA, Parikh SM, Bangirana P, Page CF, Opoka RO, Giordani B. A pilot study of the neuropsychological benefits of computerized cognitive rehabilitation in Ugandan children with HIV. Neuropsychology 2010; 24:667-673.
44. Wang H, Zhou J, Huang L, Li X, Fennie KP, Williams AB. Effects of nurse-delivered home visits combined with telephone calls on medication adherence and quality of life in HIV-infected heroin users in Hunan of China. J Clin Nurs 2010; 19:380-388.
45. Olley BO. Improving well being through psycho-education among voluntary counseling and testing seekers in Nigeria: a controlled outcome study. AIDS Care 2006; 18:1025-1031. (Pubitemid 44521860)
46. Futterman D, Shea J, Besser M, Stafford S, Desmond K, Comulada WS, Greco E. Mamekhaya: a pilot study combining a cognitive-behavioral intervention and mentor mothers with PMTCT services in South Africa. AIDS Care 2010; 22:1093-1100.
47. Andersen L. Effectiveness of cognitive-behavioral therapy on the reduction of depression in people infected with HIV/AIDS in South Africa HOFSTRA University; 2009.
48. Papas RK, Sidle JE, Martino S, Baliddawa JB, Songole R, Omolo OE, et al. Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav 2010; 14:669-678.
49. Van Winghem J, Telfer B, Reid T, Ouko J, Mutunga A, Jama Z, Vakil S. Implementation of a comprehensive program including psycho-social and treatment literacy activities to improve adherence to HIV care and treatment for a pediatric population in Kenya. BMC Pediatr 2008; 8:52.
50. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3:e438; Review.
51. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004; 94:1133-1140. (Pubitemid 38857313)
52. Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and healthcare utilization. Drug Alcohol Depend 2010; 112:178-193; Epub 2010 Aug 11. Review.
53. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and metaanalysis. J Acquir Immune Defic Syndr 2009; 52:180-202; Review.
54. Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses 2010; 26:511-518.
55. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A. No health without mental health. Lancet 2007; 370:859-877; Review. (Pubitemid 47371145)
56. Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and metaanalysis. AIDS Patient Care STDS 2007; 21:732-739; Review. (Pubitemid 47614389)
57. Scott-Sheldon LA, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIVR adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol 2008; 27:129-133.
58. Crepaz N, Passin WF, Herbst JH, Rama SM, Malow RM, Purcell DW, Wolitski RJ, HIV/AIDS Prevention Research Synthesis Team. Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning. Health Psychol 2008; 27:4-14. (Pubitemid 351217074)
59. Safren SA, O'Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, Mayer KH. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol 2009; 28:1-10.
60. Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA, National Institute of Mental Health Healthy Living Project Team. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr 2007; 46:574-580. (Pubitemid 350191050)
61. Gonzalez JS, Penedo FJ, Llabre MM, Durán RE, Antoni MH, Schneiderman N, Horne R. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med 2007; 34:46-55. (Pubitemid 47481224)
62. Horne R, Cooper V, Gellaitry G, Date HL, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessityconcerns framework. J Acquir Immune Defic Syndr 2007; 45:334-341. (Pubitemid 47012382)
63. Lovejoy TI, Suhr JA. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review. J Behav Med 2009; 32:389-405; Epub 2009 Mar 17. Review.
64. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al., ART-LINC, IeDEA. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 2008; 86:559-567. (Pubitemid 351931216)
65. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al. Mortality and loss-to-follow-up during the pretreatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009; 9:290.
66. CarricoAW, RileyED, JohnsonMO, Charlebois ED, Neilands TB, Remien RH, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. J Acquir Immune Defic Syndr 2011; 56:146-150.